NO20091480L - Aminometyl-2-imidazoler med affinitet mot sporamin-assosierte reseptorer - Google Patents
Aminometyl-2-imidazoler med affinitet mot sporamin-assosierte reseptorerInfo
- Publication number
- NO20091480L NO20091480L NO20091480A NO20091480A NO20091480L NO 20091480 L NO20091480 L NO 20091480L NO 20091480 A NO20091480 A NO 20091480A NO 20091480 A NO20091480 A NO 20091480A NO 20091480 L NO20091480 L NO 20091480L
- Authority
- NO
- Norway
- Prior art keywords
- disorders
- compounds
- disease
- formula
- associated receptors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychology (AREA)
- Addiction (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Foreliggende oppfinnelse angår forbindelser med formel (I) og til deres farmasøytisk aktive salter. Det er funnet at forbindelsene med formel I har en god affinitet til spor-amin assosierte reseptorer (TAAR) og spesielt TAAR1. Forbindelsene kan anvendes for behandling av depresjon, angst lidelser, bipolar lidelse, oppmerksomhetssvikt hyperaktivitetslidelse (ADHD), stress-relaterte lidelser, psykotiske lidelser så som schizofreni, nevrologiske sykdommer så som Parkinsons sykdom, neurodegenerative lidelser så som Alzheimers sykdom, epilepsi, migrene, hypertensjon, stoffmisbruk og metabolske lidelser så som spiseforstyrrelser, diabetes, diabetiske komplikasjoner, fedme, dyslipidemi, lidelser knyttet til energikonsum og tilpasning, lidelser og svikt knyttet til kroppstemperatur homeostase, søvnforstyrrelser og forstyrrelser knyttet til døgnrytmen og kardiovaskulære lidelser.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06122553 | 2006-10-19 | ||
PCT/EP2007/060664 WO2008046756A1 (en) | 2006-10-19 | 2007-10-09 | Aminomethyl-2-imidazoles with affinity with the trace amine associated receptors |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20091480L true NO20091480L (no) | 2009-04-30 |
Family
ID=38819769
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20091480A NO20091480L (no) | 2006-10-19 | 2009-04-17 | Aminometyl-2-imidazoler med affinitet mot sporamin-assosierte reseptorer |
Country Status (21)
Country | Link |
---|---|
US (1) | US20080096906A1 (no) |
EP (1) | EP2076496B1 (no) |
JP (1) | JP5167265B2 (no) |
KR (1) | KR101172940B1 (no) |
CN (1) | CN101528709B (no) |
AR (1) | AR063326A1 (no) |
AT (1) | ATE462696T1 (no) |
AU (1) | AU2007312389B2 (no) |
BR (1) | BRPI0718059A2 (no) |
CA (1) | CA2665255A1 (no) |
CL (1) | CL2007002970A1 (no) |
DE (1) | DE602007005671D1 (no) |
ES (1) | ES2340223T3 (no) |
IL (1) | IL197872A (no) |
MX (1) | MX2009003887A (no) |
NO (1) | NO20091480L (no) |
PE (1) | PE20080984A1 (no) |
RU (1) | RU2009112495A (no) |
TW (1) | TW200835494A (no) |
WO (1) | WO2008046756A1 (no) |
ZA (1) | ZA200902279B (no) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI1976828T1 (sl) | 2005-12-29 | 2017-07-31 | Celtaxsys, Inc. | Diaminski derivati kot inhibitorji levkotrien A4 hidrolaze |
ES2381589T3 (es) | 2006-10-19 | 2012-05-29 | F. Hoffmann-La Roche Ag | Aminometil-4-imidazoles |
KR20110079776A (ko) * | 2006-10-19 | 2011-07-07 | 에프. 호프만-라 로슈 아게 | 당뇨병을 위한 11베타-에이치에스디1 억제제로서의 이미다졸론 및 이미다졸리딘온 유도체 |
RU2010104632A (ru) * | 2007-07-27 | 2011-09-20 | Ф.Хоффманн-Ля Рош Аг (Ch) | 2-азетидинметанамины и 2-пирролидинметанамины в качестве лигандов taar |
US8242153B2 (en) * | 2008-07-24 | 2012-08-14 | Hoffmann-La Roche Inc. | 4,5-dihydro-oxazol-2YL derivatives |
ES2864862T3 (es) | 2013-03-12 | 2021-10-14 | Celltaxis Llc | Métodos de inhibición de la leucotrieno A4 hidrolasa |
WO2014152536A2 (en) | 2013-03-14 | 2014-09-25 | Celtaxsys, Inc. | Inhibitors of leukotriene a4 hydrolase |
AU2014239567B2 (en) | 2013-03-14 | 2017-12-14 | Celtaxsys, Inc. | Inhibitors of leukotriene A4 hydrolase |
RU2696559C2 (ru) * | 2013-03-14 | 2019-08-05 | Селтакссис, Инк. | Ингибиторы лейкотриен а4-гидролазы |
US10898484B2 (en) | 2018-05-31 | 2021-01-26 | Celltaxis, Llc | Method of reducing pulmonary exacerbations in respiratory disease patients |
CN115073273A (zh) * | 2021-03-15 | 2022-09-20 | 中国医学科学院药物研究所 | 二苯烷类化合物及其制备方法、药物组合物和用途 |
JP2024511828A (ja) * | 2021-03-29 | 2024-03-15 | シューチン バイオファーマ カンパニー リミテッド | スピロ環含有誘導体、その調製方法及び使用 |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2731471A (en) * | 1956-01-17 | Nxg hi | ||
US2161938A (en) * | 1934-07-31 | 1939-06-13 | Soc Of Chemical Ind | Imidazolines |
US2457047A (en) * | 1946-02-13 | 1948-12-21 | Monsanto Chemicals | 2-(2'-thenyl)-4, 5-dihydroimidazoles and process for making the same |
US2778836A (en) * | 1954-04-02 | 1957-01-22 | Union Chimique Belge Sa | Substituted 2-methyl-delta2 imidazolines |
US2744910A (en) * | 1955-06-27 | 1956-05-08 | Bristol Lab Inc | 2-(ortho-benzylbenzyl)-imidazoline and acid addition salts |
US2744909A (en) * | 1955-06-27 | 1956-05-08 | Bristol Lab Inc | 2-(ortho-phenylbenzyl) imidazoline and acid addition salts |
US2919274A (en) * | 1957-09-17 | 1959-12-29 | Sahyun Melville | Amidines |
DE1121054B (de) * | 1960-11-23 | 1962-01-04 | Merck Ag E | Verfahren zur Herstellung eines neuen Imidazolinderivates und dessen Saeureadditionssalzen |
DE1150180B (de) * | 1962-04-12 | 1963-06-12 | Merck Ag E | Mittel zur Vorbehandlung der Haut fuer die Rasur |
US3377247A (en) * | 1967-04-28 | 1968-04-09 | Dow Chemical Co | Antidepressant method |
US3586695A (en) * | 1968-01-26 | 1971-06-22 | Dow Chemical Co | Substituted imidazolinyl indoles |
BE754935A (fr) * | 1969-08-13 | 1971-02-17 | Hoechst Ag | 2-(thienyl-3'-amino)-1,3-diazacycloalcenes et leur preparation |
US3622579A (en) * | 1969-08-28 | 1971-11-23 | Boehringer Sohn Ingelheim | Derivatives of 2-anilino-1,3-diazacyclopentene-(2) |
US3818094A (en) * | 1969-08-28 | 1974-06-18 | Boehringer Sohn Ingelheim | Hypotensive pharmaceutical compositions containing certain 2-anilino-1,3-diazacyclopentenes-(2) |
US3660423A (en) * | 1970-02-13 | 1972-05-02 | Dow Chemical Co | 2-(substituted benzyl)methyl-2-imidazolines |
DE2046785A1 (en) * | 1970-09-23 | 1972-03-30 | Badische Anilin- & Soda-Fabrik Ag, 6700 Ludwigshafen | Basic mono-azo dyes - for synthetic fibres, cotton silk, leather, paper and paints |
GB1333471A (en) * | 1971-01-27 | 1973-10-10 | Labaz | Imidazoline derivatives and process for preparing the same |
US4125620A (en) * | 1974-10-01 | 1978-11-14 | Boehringer Ingelheim Gmbh | 2-[(2',6'-Disubstituted-phenyl)-imino]-imidazolidines and salts thereof |
US3992403A (en) * | 1975-05-30 | 1976-11-16 | Schering Corporation | 2-Imidazolines and their use as hypoglycemic agents |
GB1538097A (en) * | 1976-01-26 | 1979-01-10 | Lafon Labor | Substituted phenyl-amidines |
US4323570A (en) * | 1978-11-15 | 1982-04-06 | Beiersdorf Aktiengesellschaft | Substituted aminopyrimidines |
US4665095A (en) * | 1985-12-11 | 1987-05-12 | Abbott Laboratories | Use of 2-[(3,5-dihalo-4-aminobenzyl)]imidazolines to stimulate alpha-1 adrenergic receptors and to treat nasal congestion |
GB9425211D0 (en) * | 1994-12-14 | 1995-02-15 | Ucb Sa | Substituted 1H-imidazoles |
US5610174A (en) * | 1995-06-02 | 1997-03-11 | Synaptic Pharmaceutical Corporation | Use of α1A -selective adrenoceptor agonists for the treatment of urinary incontinence |
US5969137A (en) * | 1996-09-19 | 1999-10-19 | Virginia Commonwealth University | Benzylamidine derivatives with serotonin receptor binding activity |
US5866579A (en) * | 1997-04-11 | 1999-02-02 | Synaptic Pharmaceutical Corporation | Imidazole and imidazoline derivatives and uses thereof |
CA2328973A1 (en) * | 1998-04-23 | 1999-10-28 | Akio Ojida | Naphthalene derivatives, their production and use |
IL147921A0 (en) * | 2002-01-31 | 2002-08-14 | Abdulrazik Mohammad | A method for treating central nervous system disorders by ocular dosing |
KR100492252B1 (ko) * | 2002-08-09 | 2005-05-30 | 한국화학연구원 | 이미다졸을 포함하는 이차아민으로 치환된 벤조피란유도체 및 그의 제조방법 |
CN101212898A (zh) * | 2005-05-03 | 2008-07-02 | 拜尔农作物科学股份公司 | 杀虫的取代的氨基烷基杂环及杂芳基衍生物 |
-
2007
- 2007-10-09 EP EP07821037A patent/EP2076496B1/en not_active Not-in-force
- 2007-10-09 CA CA002665255A patent/CA2665255A1/en not_active Abandoned
- 2007-10-09 AT AT07821037T patent/ATE462696T1/de active
- 2007-10-09 AU AU2007312389A patent/AU2007312389B2/en not_active Ceased
- 2007-10-09 DE DE602007005671T patent/DE602007005671D1/de active Active
- 2007-10-09 JP JP2009532766A patent/JP5167265B2/ja not_active Expired - Fee Related
- 2007-10-09 KR KR1020097007959A patent/KR101172940B1/ko not_active IP Right Cessation
- 2007-10-09 MX MX2009003887A patent/MX2009003887A/es active IP Right Grant
- 2007-10-09 CN CN2007800387578A patent/CN101528709B/zh not_active Expired - Fee Related
- 2007-10-09 ES ES07821037T patent/ES2340223T3/es active Active
- 2007-10-09 WO PCT/EP2007/060664 patent/WO2008046756A1/en active Application Filing
- 2007-10-09 BR BRPI0718059-4A patent/BRPI0718059A2/pt not_active IP Right Cessation
- 2007-10-09 RU RU2009112495/04A patent/RU2009112495A/ru not_active Application Discontinuation
- 2007-10-15 US US11/872,192 patent/US20080096906A1/en not_active Abandoned
- 2007-10-17 PE PE2007001406A patent/PE20080984A1/es not_active Application Discontinuation
- 2007-10-17 TW TW096138927A patent/TW200835494A/zh unknown
- 2007-10-17 CL CL200702970A patent/CL2007002970A1/es unknown
- 2007-10-17 AR ARP070104589A patent/AR063326A1/es not_active Application Discontinuation
-
2009
- 2009-03-26 IL IL197872A patent/IL197872A/en not_active IP Right Cessation
- 2009-04-01 ZA ZA200902279A patent/ZA200902279B/xx unknown
- 2009-04-17 NO NO20091480A patent/NO20091480L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PE20080984A1 (es) | 2008-07-19 |
IL197872A (en) | 2012-12-31 |
AU2007312389B2 (en) | 2012-02-23 |
JP5167265B2 (ja) | 2013-03-21 |
CN101528709A (zh) | 2009-09-09 |
ATE462696T1 (de) | 2010-04-15 |
EP2076496A1 (en) | 2009-07-08 |
BRPI0718059A2 (pt) | 2013-11-05 |
DE602007005671D1 (de) | 2010-05-12 |
IL197872A0 (en) | 2009-12-24 |
TW200835494A (en) | 2008-09-01 |
MX2009003887A (es) | 2009-04-22 |
RU2009112495A (ru) | 2010-11-27 |
US20080096906A1 (en) | 2008-04-24 |
EP2076496B1 (en) | 2010-03-31 |
CL2007002970A1 (es) | 2008-05-30 |
KR20090055640A (ko) | 2009-06-02 |
KR101172940B1 (ko) | 2012-08-10 |
CA2665255A1 (en) | 2008-04-24 |
AR063326A1 (es) | 2009-01-21 |
JP2010506874A (ja) | 2010-03-04 |
WO2008046756A1 (en) | 2008-04-24 |
AU2007312389A1 (en) | 2008-04-24 |
ZA200902279B (en) | 2010-03-31 |
ES2340223T3 (es) | 2010-05-31 |
CN101528709B (zh) | 2012-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20091480L (no) | Aminometyl-2-imidazoler med affinitet mot sporamin-assosierte reseptorer | |
TW200833685A (en) | Aminomethyl-4-imidazoles | |
WO2011057973A9 (en) | Oxazoline derivatives for treatment of cns disorders | |
NZ599577A (en) | Substituted benzamide derivatives | |
WO2009003868A3 (en) | 2 -imidazolines having a good affinity to the trace amine associated receptors (taars) | |
NO20083356L (no) | Anvendelse av 4-imidazolderivater for CNS sykdommer | |
SG195156A1 (en) | Pyrazole derivatives | |
MX351918B (es) | Derivados heterociclicos de amina. | |
EA201001737A1 (ru) | Новые производные nip тиазола в качестве ингибиторов 11-бета-гидроксистероид дегидрогеназы-1 | |
NO20083349L (no) | Anvendelse av 2-imidazoler for behandling av CNS sykdommer | |
CO6331336A2 (es) | Derivados de 4,5-dihidro-oxazol-2-ilo | |
MX2009005920A (es) | Nuevos 2-imidazoles como ligandos para receptores asociados con trazas de amina. | |
MX354815B (es) | Derivados heterociclicos como receptores asociados con las aminas traza (taars). | |
MX361761B (es) | Derivados de triazol carboxamida. | |
NO20091936L (no) | 4-imidazoliner som TAAR ligander | |
MX2009013745A (es) | 4-imidazolinas y su uso como antidepresivos. | |
PH12015500489A1 (en) | Pyrazole carboxamide derivatives as taar modulators for use in the treatment of several disorders, such as depression, diabetes and parkinsons disease | |
MX2016013412A (es) | Derivados de morfolina-piridina. | |
MX2009004617A (es) | 2-imidazoles sustituidos como moduladores de los receptores asociados con trazas de amina. | |
WO2007090720A3 (en) | Use of 2-imidazoles for the treatment of cns disorders | |
NO20091721L (no) | Substituerte 4-imidazoler | |
MX349738B (es) | Derivados de dihidrooxazol-2-amina. | |
MX2016012624A (es) | Derivados de 5-oxa-2-azabiciclo[2.2.2]octan-4-ilo y 5-oxa-2-azabiciclo[2.2.1]heptan-4-ilo como modularores de los receptores asociados a la amina de trazas 1 (taar1). | |
TH103564A (th) | 2-อะเซทิดีนมีเธนเอมีน และ 2-ไพร์โรลิดีนมีเธนเอมีน ในฐานะเป็น taar-ลิแกนด์ | |
TH95089B (th) | 4-อิมิดาโซลที่ถูกแทนที่ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |